Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19. Hoogenboom WS, Lu JQ, Musheyev B, Borg L, et al. PLoS One 2022;17:e0262811.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hoogenboom WS, Lu JQ, Musheyev B, Borg L, et al. Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19. PLoS One 2022;17:e0262811.
PMID: 35045130